vs
Aclarion, Inc.（ACON）与AMERICAN SHARED HOSPITAL SERVICES（AMS）财务数据对比。点击上方公司名可切换其他公司
AMERICAN SHARED HOSPITAL SERVICES的季度营收约是Aclarion, Inc.的418.2倍（$7.7M vs $18.5K）。AMERICAN SHARED HOSPITAL SERVICES净利率更高（-8.2% vs -10223.7%，领先10215.6%）。Aclarion, Inc.同比增速更快（80.6% vs -14.8%）。过去两年Aclarion, Inc.的营收复合增速更高（35.2% vs 21.7%）
Aclarion, Inc.是一家专注于慢性下背痛诊疗的医疗科技企业，核心产品基于专利磁共振波谱技术，可精准识别患者的疼痛性椎间盘，服务美国市场的医疗机构与患者，业务覆盖慢性疼痛管理、脊柱护理两大核心领域。
美国共享医院服务公司为医疗机构提供放射治疗、立体定向放射外科及诊断成像设备的整体外包解决方案，免除医院高昂的前期资本投入，主要业务覆盖北美，同时服务拉美及部分亚太地区的公立、私立医院客户。
ACON vs AMS — 直观对比
营收规模更大
AMS
是对方的418.2倍
$18.5K
营收增速更快
ACON
高出95.4%
-14.8%
净利率更高
AMS
高出10215.6%
-10223.7%
两年增速更快
ACON
近两年复合增速
21.7%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $18.5K | $7.7M |
| 净利润 | $-1.9M | $-631.0K |
| 毛利率 | 9.7% | 11.7% |
| 营业利润率 | -10785.8% | -18.1% |
| 净利率 | -10223.7% | -8.2% |
| 营收同比 | 80.6% | -14.8% |
| 净利润同比 | 5.0% | 52.5% |
| 每股收益（稀释后） | $1.39 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACONAMS
| Q4 25 | $18.5K | $7.7M | ||
| Q3 25 | $18.9K | $7.2M | ||
| Q2 25 | $19.3K | $7.1M | ||
| Q1 25 | $19.0K | $6.1M | ||
| Q4 24 | $10.2K | $9.1M | ||
| Q3 24 | $14.4K | $7.0M | ||
| Q2 24 | $11.0K | $7.1M | ||
| Q1 24 | $10.1K | $5.2M |
净利润ACONAMS
| Q4 25 | $-1.9M | $-631.0K | ||
| Q3 25 | $-1.7M | $-17.0K | ||
| Q2 25 | $-1.6M | $-280.0K | ||
| Q1 25 | $-2.0M | $-625.0K | ||
| Q4 24 | $-2.0M | $-1.3M | ||
| Q3 24 | $-1.4M | $-207.0K | ||
| Q2 24 | $-1.2M | $3.6M | ||
| Q1 24 | $-2.4M | $119.0K |
毛利率ACONAMS
| Q4 25 | 9.7% | 11.7% | ||
| Q3 25 | 23.2% | 22.1% | ||
| Q2 25 | 26.6% | 23.1% | ||
| Q1 25 | -23.6% | 15.4% | ||
| Q4 24 | -100.9% | 35.3% | ||
| Q3 24 | -48.1% | 19.6% | ||
| Q2 24 | -112.3% | 35.0% | ||
| Q1 24 | -92.6% | 41.1% |
营业利润率ACONAMS
| Q4 25 | -10785.8% | -18.1% | ||
| Q3 25 | -9666.2% | -4.8% | ||
| Q2 25 | -8988.6% | -7.7% | ||
| Q1 25 | -7856.0% | -21.3% | ||
| Q4 24 | -17652.7% | -20.2% | ||
| Q3 24 | -8995.3% | -12.7% | ||
| Q2 24 | -10350.6% | -0.0% | ||
| Q1 24 | -12609.3% | -1.6% |
净利率ACONAMS
| Q4 25 | -10223.7% | -8.2% | ||
| Q3 25 | -9008.0% | -0.2% | ||
| Q2 25 | -8285.9% | -4.0% | ||
| Q1 25 | -10728.4% | -10.2% | ||
| Q4 24 | -19444.6% | -14.6% | ||
| Q3 24 | -9482.7% | -3.0% | ||
| Q2 24 | -11285.0% | 51.0% | ||
| Q1 24 | -23720.6% | 2.3% |
每股收益（稀释后）ACONAMS
| Q4 25 | $1.39 | $-0.09 | ||
| Q3 25 | $-2.93 | $0.00 | ||
| Q2 25 | $-2.75 | $-0.04 | ||
| Q1 25 | $-9.32 | $-0.10 | ||
| Q4 24 | $-809.36 | $-0.21 | ||
| Q3 24 | $-1321.49 | $-0.03 | ||
| Q2 24 | $-1362.83 | $0.55 | ||
| Q1 24 | $-3985.22 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.0M | $3.5M |
| 总债务越低越好 | — | $17.4M |
| 股东权益账面价值 | $12.8M | $24.0M |
| 总资产 | $13.7M | $55.5M |
| 负债/权益比越低杠杆越低 | — | 0.72× |
8季度趋势，按日历期对齐
现金及短期投资ACONAMS
| Q4 25 | $12.0M | $3.5M | ||
| Q3 25 | $11.3M | $5.1M | ||
| Q2 25 | $12.8M | $11.1M | ||
| Q1 25 | $14.8M | $11.2M | ||
| Q4 24 | $453.7K | $11.0M | ||
| Q3 24 | $1.3M | $13.8M | ||
| Q2 24 | $1.2M | $14.2M | ||
| Q1 24 | $2.1M | $12.8M |
总债务ACONAMS
| Q4 25 | — | $17.4M | ||
| Q3 25 | — | $18.2M | ||
| Q2 25 | — | $19.1M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | — | $20.4M | ||
| Q3 24 | — | $14.4M | ||
| Q2 24 | — | $15.1M | ||
| Q1 24 | — | $15.6M |
股东权益ACONAMS
| Q4 25 | $12.8M | $24.0M | ||
| Q3 25 | $12.5M | $24.6M | ||
| Q2 25 | $14.2M | $24.5M | ||
| Q1 25 | $15.8M | $24.6M | ||
| Q4 24 | $970.1K | $25.2M | ||
| Q3 24 | $2.5M | $26.4M | ||
| Q2 24 | $1.6M | $26.5M | ||
| Q1 24 | $2.5M | $22.8M |
总资产ACONAMS
| Q4 25 | $13.7M | $55.5M | ||
| Q3 25 | $13.2M | $59.6M | ||
| Q2 25 | $14.8M | $63.5M | ||
| Q1 25 | $16.5M | $63.3M | ||
| Q4 24 | $2.1M | $60.2M | ||
| Q3 24 | $3.2M | $63.3M | ||
| Q2 24 | $3.1M | $60.8M | ||
| Q1 24 | $3.7M | $50.1M |
负债/权益比ACONAMS
| Q4 25 | — | 0.72× | ||
| Q3 25 | — | 0.74× | ||
| Q2 25 | — | 0.78× | ||
| Q1 25 | — | 0.81× | ||
| Q4 24 | — | 0.81× | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | — | 0.68× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.6M | $-704.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-2.7M |
| 自由现金流率自由现金流/营收 | — | -34.8% |
| 资本支出强度资本支出/营收 | — | 25.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-8.5M |
8季度趋势，按日历期对齐
经营现金流ACONAMS
| Q4 25 | $-1.6M | $-704.0K | ||
| Q3 25 | $-1.2M | $1.7M | ||
| Q2 25 | $-1.9M | $-372.0K | ||
| Q1 25 | $-2.5M | $2.5M | ||
| Q4 24 | $-922.9K | $274.0K | ||
| Q3 24 | $-1.1M | $472.0K | ||
| Q2 24 | $-1.1M | $1.3M | ||
| Q1 24 | $-2.2M | $-1.9M |
自由现金流ACONAMS
| Q4 25 | — | $-2.7M | ||
| Q3 25 | $-1.2M | $-2.0M | ||
| Q2 25 | — | $-2.3M | ||
| Q1 25 | — | $-1.5M | ||
| Q4 24 | — | $-4.4M | ||
| Q3 24 | — | $-407.0K | ||
| Q2 24 | — | $70.0K | ||
| Q1 24 | — | $-3.0M |
自由现金流率ACONAMS
| Q4 25 | — | -34.8% | ||
| Q3 25 | -6164.6% | -28.3% | ||
| Q2 25 | — | -32.1% | ||
| Q1 25 | — | -24.7% | ||
| Q4 24 | — | -48.4% | ||
| Q3 24 | — | -5.8% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | -58.4% |
资本支出强度ACONAMS
| Q4 25 | — | 25.7% | ||
| Q3 25 | 38.6% | 51.6% | ||
| Q2 25 | — | 26.9% | ||
| Q1 25 | — | 65.7% | ||
| Q4 24 | — | 51.4% | ||
| Q3 24 | 0.0% | 12.6% | ||
| Q2 24 | — | 17.2% | ||
| Q1 24 | — | 22.7% |
现金转化率ACONAMS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.36× | ||
| Q1 24 | — | -15.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACON
暂无分部数据
AMS
| Direct Patient Services | $4.0M | 51% |
| Rental Income From Medical Services | $2.7M | 35% |
| Pbrt Services | $1.2M | 15% |
